Dinoprostone
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dinoprostone and local guidelines before prescribing.
Prostaglandin analogue
Mechanism
Prostaglandin E2.
Uses
Cervical ripening and induction of labour.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Uterine hyperstimulation, nausea, fever.
Interactions
Oxytocin potentiates.
Contraindications and cautions
Previous uterine surgery, fetal distress
Monitoring
CTG
Pregnancy and breastfeeding
Obstetric use only
Renal and hepatic impairment
No adjustment
Overdose and reversal
Remove insert; tocolytic
Special advice
Fetal monitoring; wait the minimum interval before oxytocin.
More from the textbook: uses, cautions and other points
- Treatment - prostaglandin E (alprostadil or dinoprostone) infusion to reopen the duct (side effect - apnoea); urgent transfer to a cardiac centre.
Paediatrics: Neonatology - Dinoprostone (PGE2 — vaginal pessary or gel) | Cervical ripening and induction of labour | Hyperstimulation; caution with previous caesarean
Obstetrics - Prostaglandin E (alprostadil or dinoprostone) infusion: Keeps the duct open, or reopens it, until surgery or a catheter procedure.
Cardiology: Congenital heart disease - Alprostadil / dinoprostone Duct-dependent lesions (neonate) | IV infusion, starting low (around 5–10 nanograms/kg/min) and titrated; higher doses for a collapsing baby. Apnoea risk - be ready to ventilate. Use BNFc and the regional protocol.
Cardiology: Congenital heart disease - Alprostadil / dinoprostone infusion | Keeps the ductus arteriosus open in duct-dependent heart disease; apnoea.
Paediatrics: Neonatology - Vaginal prostaglandin E2 (dinoprostone - gel, tablet or pessary) or oral misoprostol - to ripen the cervix.
Obstetrics: Complications - Dinoprostone (PGE2) / oral misoprostol | Cervical ripening for induction; hyperstimulation risk.
Obstetrics: Complications - Contractions every 90 seconds with fetal decelerations after dinoprostone | Uterine hyperstimulation
Obstetrics: Complications
Where it is discussed in the book
- Cardiology: Congenital heart disease (2 mentions)
- Paediatrics: Neonatology (2 mentions)
- Obstetrics (1 mention)
- Obstetrics: Complications (3 mentions)
- Integrated cardiology chapter (2 mentions)
- Integrated paediatrics chapter (2 mentions)